Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pig influenza vaccine study shows promising results
“To our knowledge this is the first evidence in a large animal that T cell responses in the lung induced by aerosol immunisation are protective” – Elma Tchlian.
Researchers used aerosol immunisation to induce T-cell responses.

Scientists at The Pirbright Institute and the University of Oxford have made what they call a “significant advance” in developing the next generation of influenza vaccines.

In a new study, the researchers immunised by aerosol pigs which had been pre-exposed to the pH1N1 strain of influenza with viral vectored vaccines (ChAdOx2 and MVA) that expressed the influenza matrix protein (M1) and nucleoprotein (NP).

By focusing on activating T-cells, rather than solely focusing on antibodies, the team hoped that the immune system would be able to respond to a greater variety of viruses.

Currently, influenza vaccines target specific strains. Finding a way to create a universal influenza vaccine that protects against multiple strains would do away with the need for a new vaccine each year as new variants emerge.

When the pigs were exposed to the H3N2 strain four weeks later, the researchers found that all three immunisations (M1, NP, and NPM1) reduced lung pathology M1 offered the greatest protection.

NP and NPM1 immunisation induced both T-cell and antibody responses, while M1 immunisation induced T-cell responses but no antibodies.

The researchers believe the breakthrough could pave the way for advances in creating the next-generation of influenza vaccines that offer protection against multiple strains.  

Dame Sarah Gilbert, professor of vaccinology at the Pandemic Sciences Institute, University of Oxford, said: “To our knowledge this is the first evidence in a large animal that T cell responses in the lung induced by aerosol immunisation are protective.

“We believe that these results are a significant advance and highly relevant to the development of next generation vaccines for influenza and other respiratory pathogens.”

Elma Tchlian, head of Pirbright’s Mucosal Immunology Group, added “This study shows the importance of targeting the respiratory tract through aerosol administration to induce local immunity and prevent severe disease.

“This approach has significant implications for both human and veterinary medicine and highlights the potential of respiratory vaccines for influenza and other respiratory pathogens.”

The study has been published in the journal NPJ Vaccines.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

VMD responds to Solensia injection concerns

News Story 1
 The VMD has added anaphylaxis to the SPC of Solensia 7 mg/ml Solution for Injection for Cats.

It says that this is a rare side effect, with such adverse events affecting fewer than three animals for every 1000 doses of Solensia sold.

Solensia is used to alleviate osteoarthritis pain in cats. It contains the active ingredient frunevetmab.

Anaphylaxis joins effects such as alopecia, dermatitis, pruritus on the list of adverse effects.

The VMD says that is constantly reviewing adverse event data for all medicines. 

Click here for more...
News Shorts
Applications open for RCVS Fellowship

The Royal College of Veterinary Surgeons (RCVS) has opened applications for veterinary surgeons to join the RCVS Fellowship.

The RCVS Fellowship is a learned society which works to advance veterinary standards and promote scientific excellence.

Veterinary surgeons can enter the RCVS Fellowship through three routes, each with different criteria. This enables people with a range of expertise and experience to join the society.

The routes are: Meritorious Contributions to Clinical Practice, Meritorious Contributions to Knowledge and Meritorious Contributions to the Profession.

Applicants must share a summary of their contributions to the profession, including examples of significant works produced throughout their career. The application will then be assessed by a panel of judges against a set of criteria.

Veterinary surgeons have until 4pm on Friday, 14 March to submit applications. More information, including requirements and guidance can be found here.